Promising Advances in Hepatitis B Treatment with New Therapies
A China-led international research team has discovered that xalnesiran, a small interfering RNA molecule, can potentially cure about one-third of hepatitis B patients when used alone or with an immunomodulator. This finding, published in The New England Journal of Medicine, marks a significant advancement in treating a virus that affects over 250 million people globally, with China having the highest number of cases. Current antiviral treatments can control but not eradicate the virus, making this discovery a promising step towards a cure.
